Plerixafor (a CXCR4 antagonist) following myeloablative allogeneic hematopoietic stem cell transplantation enhances hematopoietic recovery. uri icon

authors

  • Green, Michael M B
  • Mims, Alice
  • Rizzieri, David
  • Sarantopoulos, Stefanie
  • Stuart, Robert
  • Anthony Sung, MD
  • Sullivan, Keith M
  • Costa, Luciano
  • Horwitz, Mitchell
  • Kang, Yubin
  • Chao, Nelson
  • Chhabra, Saurabh
  • Corbet, Kelly
  • Gasparetto, Cristina
  • Horwitz, Ari
  • Li, Zhiguo
  • Venkata, Jagadish Kummetha
  • Long, Gwynn

publication date

  • January 1, 2016